Annual report
3937.TEDINET S100R7QQ
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥4.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥4.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥877m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥716m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥591m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥926m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥574m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥832m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥624m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥533m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥369m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥574m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥832m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥5.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥5.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.7bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.9bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥874m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥922m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥499m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥568m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥203m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥61m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥69m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥207m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥447m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥152m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥76m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥96m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥59m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥48.68 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.25 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.17 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.57 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥47.57 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.49 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51.75 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.81 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.43 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥348.19 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥322.44 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥249.28 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥190.24 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥147.18 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 27.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.7% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,065 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 947 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 935 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,021 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 955 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥1.8bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥7m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥35m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥226m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥233m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥88m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥59m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥62m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥148m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥216m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥177m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥384m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥200m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥728,000 | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥142m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥530m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥308m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥685m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥578m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥15 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.45 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.11 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.06 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.52 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥14.66 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.57 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.63 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.08 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥11 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥9 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥164.58 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥173.83 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.07 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥130.97 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥134.95 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.2% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 11,873,840 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,834,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,802,880 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,657,120 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,483,360 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 57 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 58 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 59 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 68 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 59 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 75
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥600,000 |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥186,000 |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥51m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥51m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥331m |
| Global Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥50m |
| Global Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥138m |
| Global Businessreportable segment | employees | at 2023-03-31 | 1004 pure |
| Global Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.8bn |
| Global Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.7bn |
| Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥42m |
| Global Businessreportable segment | segment assets | at 2023-03-31 | ¥2.4bn |
| Global Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥446m |
| Medical Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥21m |
| Medical Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥13m |
| Medical Businessreportable segment | employees | at 2023-03-31 | 47 pure |
| Medical Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| Medical Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| Medical Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥9m |
| Medical Businessreportable segment | segment assets | at 2023-03-31 | ¥2.3bn |
| Medical Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥896m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥71m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥151m |
| —segment total | employees | at 2023-03-31 | 1051 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥5.3bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥51m |
| —segment total | segment assets | at 2023-03-31 | ¥4.7bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥71m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥151m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥5.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥51m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥720,000 |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥76m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥76m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥983m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥309m |
| Global Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥251m |
| Global Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥96m |
| Global Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.3bn |
| Global Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| Global Businessreportable segment | segment assets | at 2022-03-31 | ¥2.4bn |
| Global Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥496m |
| Medical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥30m |
| Medical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Medical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Medical Businessreportable segment | segment assets | at 2022-03-31 | ¥2.3bn |
| Medical Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥847m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥281m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| —segment total | segment assets | at 2022-03-31 | ¥4.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥281m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Global Businessreportable segment | employees | at 2023-03-31 | 43 pure |
| —segment total | employees | at 2023-03-31 | 43 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,466
| Item | Context | Value | Unit |
|---|---|---|---|
| Asset retirement obligations ncl | CurrentYearInstant | 16256000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 347110000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 370253000 | JPY |
| Liabilities | Prior1YearInstant | 1811642000 | JPY |
| Liabilities | CurrentYearInstant | 1706809000 | JPY |
| Capital stock | Prior1YearInstant | 788949000 | JPY |
| Capital stock | CurrentYearInstant | 799706000 | JPY |
| Capital surplus | Prior1YearInstant | 693565000 | JPY |
| Capital surplus | CurrentYearInstant | 704322000 | JPY |
| Retained earnings | Prior1YearInstant | 2270297000 | JPY |
| Retained earnings | CurrentYearInstant | 2737681000 | JPY |
| Treasury stock | Prior1YearInstant | -25588000 | JPY |
| Treasury stock | CurrentYearInstant | -295612000 | JPY |
| Shareholders equity | Prior1YearInstant | 3727224000 | JPY |
| Shareholders equity | CurrentYearInstant | 3946098000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 12936000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 71248000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 62731000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 128156000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 9451000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | -55262000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 85118000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 144142000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 182000 | JPY |
| Subscription rights to shares | CurrentYearInstant | 168000 | JPY |
| Net assets | Prior1YearInstant | 3812525000 | JPY |
| Net assets | CurrentYearInstant | 4090409000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 5624167000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 5797219000 | JPY |
| Net sales | Prior1YearDuration | 4726359000 | JPY |
| Net sales | CurrentYearDuration | 5246671000 | JPY |
| Cost of sales | Prior1YearDuration | 2722884000 | JPY |
| Cost of sales | CurrentYearDuration | 3195981000 | JPY |
| Gross profit | Prior1YearDuration | 2003474000 | JPY |
| Gross profit | CurrentYearDuration | 2050690000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 970239000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 1039099000 | JPY |
| Operating income | Prior1YearDuration | 1033235000 | JPY |
| Operating income | CurrentYearDuration | 1011591000 | JPY |
| Interest income noi | Prior1YearDuration | 338000 | JPY |
| Interest income noi | CurrentYearDuration | 1030000 | JPY |
| Equity in earnings of affiliates noi | Prior1YearDuration | － | JPY |
| Equity in earnings of affiliates noi | CurrentYearDuration | 7583000 | JPY |
| Gain on investments in partnership noi | Prior1YearDuration | 38378000 | JPY |
| Gain on investments in partnership noi | CurrentYearDuration | － | JPY |
| Insurance premiums refunded cancellation noi | Prior1YearDuration | 3833000 | JPY |
| Insurance premiums refunded cancellation noi | CurrentYearDuration | 21837000 | JPY |
| Subsidy income noi bounty | Prior1YearDuration | 2140000 | JPY |
| Subsidy income noi bounty | CurrentYearDuration | 1650000 | JPY |
| Contract termination gains noi | Prior1YearDuration | 10000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |